85,183,987 ordinary shares fully paid issued at $0.30 per share just just 10 months ago, nothing changed slightly goods news & net profits earned, seems undervalued at 9m MC.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status